Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Lymphoma, Mantle-Cell × polatuzumab vedotin × Clear all

Phase

Status

Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Dendritic Cell Sarcoma, Interdigitating 2 Lymphoma, Mantle-Cell 1

Interventions

zanubrutinib 4 obinutuzumab 4 orelabrutinib 2 glofitamab 2 fludarabine 2 Rituximab 2 Immunotherapy, Adoptive 2 Cyclophosphamide 2 Bendamustine Hydrochloride 2 venetoclax 1 tafasitamab 1 resiniferatoxin 1 polatuzumab vedotin 1 Lenalidomide 1 Interleukin-2 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04913103 2021-06-04

CLSGMCLPOLA

Czech Lymphoma Study Group

Phase 2 Not yet recruiting

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡